These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7647158)

  • 1. Factors influencing efficacy of exogenous surfactant in acute lung injury.
    Lewis JF; Veldhuizen RA
    Biol Neonate; 1995; 67 Suppl 1():48-60. PubMed ID: 7647158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant: current and potential therapeutic application in infants and adults.
    Lewis J; Veldhuizen RA
    J Aerosol Med; 1996; 9(1):143-54. PubMed ID: 10160204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury.
    Lewis JF; McCaig L
    Am Rev Respir Dis; 1993 Nov; 148(5):1187-93. PubMed ID: 8239152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of exogenous surfactant in the treatment of acute lung injury.
    Lewis JF; Veldhuizen R
    Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant and the adult respiratory distress syndrome.
    Lewis JF; Jobe AH
    Am Rev Respir Dis; 1993 Jan; 147(1):218-33. PubMed ID: 8420422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].
    Lauer S; Fischer LG; Stubbe HD; Van Aken H; Westphal M
    Anaesthesist; 2006 Apr; 55(4):433-42. PubMed ID: 16440205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
    Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
    Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant replacement therapy for adult respiratory distress syndrome in children.
    Evans DA; Wilmott RW; Whitsett JA
    Pediatr Pulmonol; 1996 May; 21(5):328-36. PubMed ID: 8726159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of exogenous surfactant in HCL-induced lung injury.
    Brackenbury AM; Puligandla PS; McCaig LA; Nikore V; Yao LJ; Veldhuizen RA; Lewis JF
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1135-42. PubMed ID: 11316649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosolized and instilled surfactant therapies for acute lung injury caused by intratracheal endotoxin in rats.
    Tashiro K; Yamada K; Li WZ; Matsumoto Y; Kobayashi T
    Crit Care Med; 1996 Mar; 24(3):488-94. PubMed ID: 8625639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant therapy in adults with acute lung injury/acute respiratory distress syndrome.
    Kesecioglu J; Haitsma JJ
    Curr Opin Crit Care; 2006 Feb; 12(1):55-60. PubMed ID: 16394785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surfactant replacement therapy increases life-span of patients with acute respiratory distress syndrome].
    Potapov AL; Novikov NIu; Tumanskiĭ VA; Babanin AA
    Klin Khir; 2013 Feb; (2):57-9. PubMed ID: 23705485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracheal acid or surfactant instillation raises alveolar surface tension.
    Nguyen TL; Perlman CE
    J Appl Physiol (1985); 2018 Nov; 125(5):1357-1367. PubMed ID: 29771610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
    Häfner D; Ibrahim M; Wollin L; Germann PG
    Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome.
    Playfor SD; Nootigattu VK
    Curr Drug Saf; 2006 May; 1(2):159-68. PubMed ID: 18690927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury.
    Lewis JF; Goffin J; Yue P; McCaig LA; Bjarneson D; Veldhuizen RA
    J Appl Physiol (1985); 1996 Apr; 80(4):1156-64. PubMed ID: 8926241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
    Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus on surfactant and inhaled nitric oxide for ARDS.
    Gadek JE
    J Aerosol Med; 1996; 9(1):155-62. PubMed ID: 10160205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of surfactant in the pathophysiology of the acute respiratory distress syndrome (ARDS).
    Hartog A; Gommers D; Lachmann B
    Monaldi Arch Chest Dis; 1995 Oct; 50(5):372-7. PubMed ID: 8541821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury. Impact on gas exchange.
    Schermuly R; Schmehl T; Günther A; Grimminger F; Seeger W; Walmrath D
    Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):445-53. PubMed ID: 9279222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.